Medical Packaging Company (EGX:MEPA)
Egypt · Delayed Price · Currency is EGP 1.610
-0.020 (-1.23%)
At close: Jun 24, 2026
Medical Packaging Company Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 98.05 | 119.77 | 130.92 | 91.02 | 59.24 | 47.01 | |
Revenue Growth (YoY) | -26.51% | -8.52% | 43.83% | 53.64% | 26.03% | 27.97% |
Cost of Revenue | 69.7 | 78.89 | 78.77 | 47.42 | 39.22 | 33.17 |
Gross Profit | 28.35 | 40.88 | 52.15 | 43.6 | 20.02 | 13.84 |
Selling, General & Admin | 18.37 | 16.38 | 10.8 | 8.17 | 4.47 | 4.84 |
Operating Expenses | 21.03 | 20.3 | 19.49 | 8.17 | 4.47 | 4.84 |
Operating Income | 7.31 | 20.58 | 32.66 | 35.43 | 15.56 | 9 |
Interest Expense | -5.3 | -3.93 | - | - | -0.87 | -0.37 |
Interest & Investment Income | 14.72 | 15.97 | 11.49 | 8.95 | 0.76 | - |
Currency Exchange Gain (Loss) | 0.16 | -0.01 | -2.77 | -17.56 | -0.24 | 0.02 |
Other Non Operating Income (Expenses) | -2.54 | -2.78 | 0.43 | -0.68 | 3.02 | -0.31 |
EBT Excluding Unusual Items | 14.37 | 29.83 | 41.8 | 26.13 | 18.22 | 8.34 |
Gain (Loss) on Sale of Assets | 0.55 | - | - | - | 0.03 | - |
Other Unusual Items | - | - | 8.66 | - | - | - |
Pretax Income | 14.93 | 29.83 | 50.46 | 26.13 | 18.25 | 8.34 |
Income Tax Expense | 4.53 | 5.6 | 13.88 | 5.03 | 12.51 | 0.66 |
Net Income | 10.4 | 24.23 | 36.58 | 21.1 | 5.74 | 7.68 |
Net Income to Common | 10.4 | 24.23 | 36.58 | 21.1 | 5.74 | 7.68 |
Net Income Growth | -74.54% | -33.76% | 73.33% | 267.78% | -25.27% | 74.25% |
Shares Outstanding (Basic) | 655 | 655 | 655 | 655 | 345 | 345 |
Shares Outstanding (Diluted) | 655 | 655 | 655 | 655 | 345 | 345 |
Shares Change (YoY) | - | - | - | 89.85% | - | - |
EPS (Basic) | 0.02 | 0.04 | 0.06 | 0.03 | 0.02 | 0.02 |
EPS (Diluted) | 0.02 | 0.04 | 0.06 | 0.03 | 0.02 | 0.02 |
EPS Growth | -74.54% | -33.76% | 73.33% | 93.72% | -25.27% | 74.25% |
Free Cash Flow | -13.22 | -15.25 | 8.35 | 6.61 | 23.46 | 10.01 |
Free Cash Flow Per Share | -0.02 | -0.02 | 0.01 | 0.01 | 0.07 | 0.03 |
Gross Margin | 28.91% | 34.13% | 39.83% | 47.90% | 33.80% | 29.44% |
Operating Margin | 7.46% | 17.18% | 24.94% | 38.92% | 26.26% | 19.14% |
Profit Margin | 10.60% | 20.23% | 27.94% | 23.18% | 9.69% | 16.33% |
Free Cash Flow Margin | -13.48% | -12.73% | 6.38% | 7.26% | 39.60% | 21.29% |
EBITDA | 14 | 27.77 | 37.82 | 40.49 | 19.85 | 12.67 |
EBITDA Margin | 14.28% | 23.19% | 28.89% | 44.49% | 33.51% | 26.96% |
D&A For EBITDA | 6.68 | 7.19 | 5.17 | 5.07 | 4.3 | 3.68 |
EBIT | 7.31 | 20.58 | 32.66 | 35.43 | 15.56 | 9 |
EBIT Margin | 7.46% | 17.18% | 24.94% | 38.92% | 26.26% | 19.14% |
Effective Tax Rate | 30.36% | 18.77% | 27.51% | 19.25% | 68.56% | 7.90% |